Tanvex Biopharma Inc. (6541)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
39. 20
+0.4
+1.0309%
NT$
11.45B Market Cap
- P/E Ratio
- Div Yield
191,226 Volume
- Eps
NT$ 38.8
Previous Close Want to track 6541 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
6541 Earnings Reports FAQ
What is the earnings per share (EPS) for 6541?
EPS data for 6541 is currently not available, as Tanvex Biopharma Inc has not reported recent earnings.
What is the company's earnings growth rate?
Tanvex Biopharma Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Tanvex Biopharma Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Tanvex Biopharma Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 6541 at this time, as Tanvex Biopharma Inc has no recent EPS data to calculate it.
